{"id":40200,"date":"2017-08-24T09:25:41","date_gmt":"2017-08-24T13:25:41","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=40200"},"modified":"2017-08-24T09:25:42","modified_gmt":"2017-08-24T13:25:42","slug":"tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200","title":{"rendered":"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)"},"content":{"rendered":"<p><strong>Tandem Diabetes Care Inc (NASDAQ:TNDM)<\/strong> has announced that it has enrolled its first patient in its trial for its t:slim X2\u2122 Insulin Pump using the company\u2019s predictive low glucose suspend (PLGS) technology. Tandem Diabetes Care is engaged in the manufacture of medical devices as well as touchscreen insulin pumps which are supplied in the United States. The company\u2019s insulin pump system which makes use of the integrated Dexcom G5\u00ae Mobile Continuous Glucose Monitor (CGM), has been designed in a way that enables it to cut off delivery of insulin when levels of glucose start to rise.<\/p>\n<p>The PROLOG study has been done on several randomized centers and compares two sessions of three weeks each. In one sessions, t:slim X2 Pump is used together with PLGS while in the second session, a standard CGM-integrated t:slim X2 Pump is used alone without any automated suspension of the insulin. A total of 90 patients with type 1 diabetes and aged 6 and above are expected to be enrolled in the study that will be done at five stations spread across the United States. The study will be coordinated by Jaeb Center on behalf of Health Research in Tampa, Florida. The study\u2019s primary endpoint is to show a drop in CGM values below the 70 mg\/dL mark in patients on Tandem\u2019s PLGS algorithm.<\/p>\n<p>In a statement, Tandem Diabetes Care president and CEO Kim Blickenstaff said the start of the study is a significant milestone in the company\u2019s program that entails building a fully automated insulin delivery system. He added that they are fully committed to submitting the t:slim X2 Pump with very low glucose suspend to the Food and Drug Administration agency early 2018. Additionally, the company intends to make the feature available to its t:slim X2 customers through a remote software update through its Tandem Device Updater<\/p>\n<p>Mild to moderate hypoglycemia is a common occurrence during the day among people with type 1 diabetes. Of more concern however is the severe hypoglycemia which mainly occurs at night and lead to seizures and in the severe cases even death. It is a major cause of worry for people suffering from type 1 diabetes as well as parents with children living with type 1 diabetes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tandem Diabetes Care Inc (NASDAQ:TNDM) has announced that it has enrolled its first patient in its trial for its t:slim X2\u2122 Insulin Pump using the [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":40209,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12847,358,12846,12845,12843,12844],"stock_ticker":[],"class_list":["post-40200","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-kim-blickenstaff","tag-nasdaq","tag-nasdaqtndm","tag-tandem-diabetes-care-inc","tag-tandem-diabetes-care-inc-nasdaqtndm","tag-tndm","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Tandem Diabetes Care Inc (NASDAQ:TNDM) has announced that it has enrolled its first patient in its trial for its t:slim X2\u2122 Insulin Pump using the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-24T13:25:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-08-24T13:25:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"639\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)\",\"datePublished\":\"2017-08-24T13:25:41+00:00\",\"dateModified\":\"2017-08-24T13:25:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\"},\"wordCount\":396,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg\",\"keywords\":[\"Kim Blickenstaff\",\"NASDAQ\",\"NASDAQ:TNDM\",\"Tandem Diabetes Care Inc\",\"Tandem Diabetes Care Inc (NASDAQ:TNDM)\",\"TNDM\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\",\"name\":\"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg\",\"datePublished\":\"2017-08-24T13:25:41+00:00\",\"dateModified\":\"2017-08-24T13:25:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg\",\"width\":960,\"height\":639},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200","og_locale":"en_US","og_type":"article","og_title":"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS) - Wall Street PR","og_description":"Tandem Diabetes Care Inc (NASDAQ:TNDM) has announced that it has enrolled its first patient in its trial for its t:slim X2\u2122 Insulin Pump using the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-08-24T13:25:41+00:00","article_modified_time":"2017-08-24T13:25:42+00:00","og_image":[{"width":960,"height":639,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)","datePublished":"2017-08-24T13:25:41+00:00","dateModified":"2017-08-24T13:25:42+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200"},"wordCount":396,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg","keywords":["Kim Blickenstaff","NASDAQ","NASDAQ:TNDM","Tandem Diabetes Care Inc","Tandem Diabetes Care Inc (NASDAQ:TNDM)","TNDM"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200","url":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200","name":"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg","datePublished":"2017-08-24T13:25:41+00:00","dateModified":"2017-08-24T13:25:42+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40208-960x0.jpg","width":960,"height":639},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/tandem-diabetes-care-inc-nasdaqtndm-begins-enrollment-in-pivotal-trial-for-first-touchscreen-insulin-pump-with-predictive-low-glucose-suspend-plgs-40200#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=40200"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40200\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/40209"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=40200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=40200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=40200"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=40200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}